AorTx raises $5.8 million for aortic valve replacement

Editor | December 12th, 2006

AorTx, a secretive Redwood City company developing a aortic valve replacement technology, has raised $5.8 million in two rounds of funding.

LinkSV reported the company raised $2.7 million earlier this year, and VentureWire reported (sub required) it has just raised more in first round, for a total of $5.8 million.

The company is moving from animal to human trials.

Investors include Bio-Star Private Equity Fund, Saratoga Ventures, MedFocus, Wilson Sonsini Goodrich & Rosati and St. Jude Medical.

Tags: , , , , ,
Sphere It Digg this story!
Trackback URL

  1. October 20th, 2007
    5:41 am

    VentureBeat » Life sciences briefing: Friday, Oct. 19, 2007 said:

    [...] field happens to be booming — we’ve previously covered competitors JenaValve, AorTx and [...]

  2. November 19th, 2007
    5:29 pm

    VentureBeat » Life sciences briefing: Monday, Nov. 19, 2007 said:

    [...] previous coverage of the company is here. AorTx had previously raised $5.8 million in two funding rounds, so the deal represents a decent [...]